Keywords: UK New Year Honours, Teva CEO succession, Andrew Witty, GlaxoSmithKline, ABPI

Knighthood for GlaxoSmithKline’s Andrew Witty; Teva succession plan

Article | 03 January 2012

Print This

Andrew Witty, chief executive of UK drug giant GlaxoSmithKline (LSE: GSK) has been awarded a Knighthood in the UK’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in